Invenomic Capital Management’s Tennant Co TNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.2M Buy
349,392
+18,218
+6% +$1.32M 1.06% 34
2025
Q4
$24.4M Buy
331,174
+1,259
+0.4% +$96.2K 1.14% 24
2025
Q3
$26.7M Sell
329,915
-20,549
-6% -$1.68M 1.29% 21
2025
Q2
$27.2M Buy
350,464
+70,664
+25% +$5.22M 1.54% 19
2025
Q1
$22.3M Buy
279,800
+205,596
+277% +$17.4M 1.13% 23
2024
Q4
$6.05M Buy
+74,204
New +$6.53M 0.29% 104

Other funds holding TNC

Invenomic Capital Management's TNC Position: Q1 2026 in Review

Invenomic Capital Management increased its Tennant Co (TNC) stake by 5.5% in Q1 2026, buying an estimated $1.32M and bringing the position to 349,392 shares worth $23.2M. The position accounts for 1.06% of the portfolio, ranked #34.

Invenomic Capital Management first reported a position in TNC in Q4 2024 and has held it in 6 quarters since. The position peaked at $27.2M in Q2 2025. 217 funds tracked by Wall St. Rank hold TNC as of Q1 2026.

  • Invenomic Capital Management held 349,392 shares of Tennant Co worth $23.2M as of Q1 2026.
  • Invenomic Capital Management bought 18,218 Tennant Co shares in Q1 2026, an estimated $1.32M.
  • Tennant Co made up 1.06% of Invenomic Capital Management's portfolio in Q1 2026, its #34 holding.
  • Invenomic Capital Management first reported a position in Tennant Co in Q4 2024 and has held it in 6 quarters since.
  • Invenomic Capital Management's Tennant Co position peaked at $27.2M in Q2 2025.
  • 217 funds tracked by Wall St. Rank held Tennant Co as of Q1 2026.

Based on Invenomic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.